Jonathan Cohen
Presidente en MESHEK ENERGY - RENEWABLE ENERGIES LTD. .
Fortuna: 517 040 $ al 30/04/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Gavriel Eichenwald | M | 69 |
Hazera (1939) Ltd.
Mishkei Renewable Energies Ltd.
| 6 años |
Raz Nur | M | 54 |
Hazera (1939) Ltd.
Mishkei Renewable Energies Ltd.
| 7 años |
Michael Lazar | M | 61 |
Mishkei Renewable Energies Ltd.
Hazera (1939) Ltd.
| 8 años |
Alon Kolet | M | 54 |
Mishkei Renewable Energies Ltd.
| 4 años |
Ran Ronen | M | 64 |
Mishkei Renewable Energies Ltd.
| 5 años |
Segev Yerovam | M | 66 |
Mishkei Renewable Energies Ltd.
| 5 años |
Yael Andorn Karni | F | 53 | 4 años | |
Sharon Arie Schlesinger | M | 56 |
Mishkei Renewable Energies Ltd.
| 4 años |
Galit Hanna Cohen Byk | F | 37 | 3 años | |
Varda Kalal | F | 56 | 4 años | |
Rogozik Ron | M | - | - | |
Shimmy Belikoff | M | - | 4 años | |
Vered Israelovitz | F | - | - | |
Lotem Or | F | 32 | 3 años | |
Ora Gilad | F | - | - | |
Doron Satt | M | - | - | |
Gil Shina | M | - | - | |
Arad Avner | M | 50 | 2 años | |
Alon Tamri | M | - | - | |
Raphael Nir | M | - |
Alma Bio Therapeutics
Alma Bio Therapeutics Miscellaneous Commercial ServicesCommercial Services Alma Bio Therapeutics is a French company that aims to restore immune resilience in patients suffering from autoimmune diseases. The private company's therapeutic approach employs the language of the immune system to improve patients' health by targeting the underlying cause of the disease. The company's treatment aims to support the immune system rather than suppressing it, restoring its natural resilience and providing improved safety and an opportunity for durable remission. Alma Bio Therapeutics has developed a breakthrough therapy that is targeted, specific, and confined to the site of disease, reinstating immune balance with no overdrive or complete suppression. The company's platform-technology is applicable to several autoimmune diseases, promising to yield a versatile pipeline. The company's lead programs are directed towards diseases of complex etiology in areas of significant unmet clinical need, with inflammatory bowel disease (IBD) as their first clinical indication. Alma Bio Therapeutics is led by a seasoned management team with extensive expertise in business development, drug development, and technology commercialization. | 10 años |
Eli Nir | M | 58 |
Bionichive Ltd.
Bionichive Ltd. Auto Parts: OEMProducer Manufacturing Bionichive Ltd. introduces Squid, a fully automated, autonomous robotic solution that combines the intelligence and flexibility of humans with the power and efficiency of robots. The company is based in Ein Habsor, Israel. The Israeli company's solution is capable of pick and put-away, floor to ceiling and retrofits onto any existing warehouse. A high-end embedded control system and smart real-time data analysis allows Bionichive’s algorithmic engine to dynamically learn problems created in one warehouse and apply resolutions to all warehouses in the network. Bionichive offers a solution based on a fleet of autonomous robots, capable of floor to ceiling pick and put-away while working alongside the labor force on existing operations. | 3 años |
Mordehay Ventura | M | 69 |
Hazera (1939) Ltd.
| - |
Ido Shavit | M | 51 |
Negev Residences - Central Cooperative Agriculture Ltd.
| - |
Alon Peled | M | 52 | - | |
Shahar Ben Moyal | M | 50 | 4 años | |
Avraham Azoulay | M | 43 |
Hazera (1939) Ltd.
| - |
Idan Ravid | M | 44 | 4 años | |
Yitzhak Bader | M | 78 |
Hazera (1939) Ltd.
| - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Dorit Ben Simon | F | 56 | - | |
Oren Groupi | M | 55 | - | |
Chen Melamed | M | 62 | - | |
Simon Charles Bellicuff | M | 62 | - |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Israel | 31 | 96.88% |
Francia | 1 | 3.13% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Jonathan Cohen
- Red Personal